News

Filter

Current filters:

South AmericaPricing

1 to 9 of 17 results

Brazil’s CMED approves price adjustment of medicines to 3.35%

04-04-2014

Brazil's National Health Surveillance Agency ANVISA’s office of pharmaceutical drug market regulation…

BrazilPharmaceuticalPricingSouth America

Eli Lilly to expand manufacturing plants in Brazil’s growing pharma market

Eli Lilly to expand manufacturing plants in Brazil’s growing pharma market

03-03-2014

US pharma major Eli Lilly’s subsidiary in Brazil will invest 15 million real ($6.4 million) over the…

BrazilEli LillyPharmaceuticalPricingProductionSouth America

Biologics reimbursement trends in Argentina, Brazil and Mexico

Biologics reimbursement trends in Argentina, Brazil and Mexico

23-12-2013

Novel biologics must demonstrate improvements in efficacy, safety and cost-benefit compared with currently…

Anti-Arthritics/RheumaticsArgentinaBiotechnologyBrazilMalaysiaMarkets & MarketingOncologyPricingSouth America

High out-of-pocket costs for DPP-IV inhibitors and GLP-1 analogues greatly limit prescribing in Brazil, Mexico and Argentina

03-07-2013

Premium-priced DPP-IV inhibitors and GLP-1 analogues used in the treatment of type 2 diabetes lack nationwide…

DiabetesMarkets & MarketingPharmaceuticalPricingSouth America

El Salvador drug price cuts of 30%-60% come into effect

04-04-2013

This week, the General Medicine Law came into effect in El Salvador, bringing with it a substantial reduction…

PharmaceuticalPricingSouth America

Entry prices for new medicines in Brazil fall 35%

25-01-2013

Economic regulation has allowed medications to arrive in the hands of Brazilians at prices 35% lower,…

PharmaceuticalPricingSouth America

Study attacks Pharma business practices in Brazil

11-12-2012

A study reported by broadcaster Deutsche Welle on the business practices of drug companies Bayer, Baxter…

BaxterBayerBoehringer IngelheimMarkets & MarketingPharmaceuticalPricingSouth America

1 to 9 of 17 results

COMPANY SPOTLIGHT

Menarini

Back to top